2024 EAHAD Lifetime Achievement Award
Celebrating Ulla Hedner and Kate Khair
The European Association for Haemophilia and Allied Disorders (EAHAD) has recognised the outstanding achievements of two women who have each made important contributions to the global bleeding disorders community and to the work of the Novo Nordisk Haemophilia Foundation (NNHF).
Prof Ulla Hedner, founding Council member of the NNHF, and Kate Khair (PhD), a passionate advocate for haemophilia care and for the role of nurses in the multidisciplinary team, are both recipients of the 2024 EAHAD Lifetime Achievement Award presented on 8 February 2024 during the 17th annual congress in Frankfurt, Germany.
Prof Hedner’s pioneering work on the use of a recombinant version of Factor VIIa along with her patient-centric dedication to haemophilia care and treatment throughout her career culminated in the 2017 publication of a book: Treating Life-Threatening Bleedings: Development of recombinant coagulation factor VIIa. She was instrumental in creating the NNHF, serving as Council Member from 2005 to 2022, and currently performs an Emeritus role within the Foundation Council.
Since becoming a registered nurse in 1981, Kate Khair has demonstrated outstanding dedication to haemophilia care and research. She is an equally strong advocate for the nurse’s role in the multi-disciplinary team. Serving as an expert volunteer in various NNHF projects from Africa to Asia for over a decade, Kate Khair remains committed to advancing haemophilia care in low- and middle-income countries.
Listen to the ‘Impacting Care’ podcast episode in which Kate Khair shares her experience as a volunteer and explains the crucial role of nurses not just in delivering care but in educating, training and communicating to support those whose lives are touched by haemophilia.
Please join us in warmly congratulating Ulla Hedner and Kate Khair for their longstanding dedication to excellence in haemophilia!